UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 21, 2026
Interparfums, Inc.
(Exact name of Registrant as specified in its charter)
|
Delaware
|
|
0-16469
|
|
13-3275609
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
Commission
File Number
|
|
(I.R.S. Employer
Identification No.)
|
551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)
212.983.2640
(Registrant’s Telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
|
|
|
|
|
|
|
Common Stock, $.001 par value per share
|
|
IPAR
|
|
The Nasdaq Stock Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Conditions
Certain portions of our press release dated January 21, 2026, a copy of
which is annexed hereto as Exhibit no. 99.1, are incorporated by reference
herein, and are filed pursuant to this Item 2.02. They are as follows:
·
The 1st,
2nd (consisting of a table), 3rd through 8th full
paragraphs relating to net sales for the fourth quarter of 2025 or the full
year ended December 31, 2025
·
The 11th
through 16th full paragraphs relating to net sales for the quarter
of 2025 or the full year ended December 31, 2025
·
The 17th
through 19th paragraphs relating to the date for the issuance of
financial results and earnings conference call details.
Item 7.01 Regulation FD Disclosure
Certain portions of our press release dated January 21, 2026, a copy of
which is annexed hereto as Exhibit no. 99.1, are incorporated by reference
herein, and are filed pursuant to this Item 7.01. They are as follows:
·
The 9th
full paragraph relating to the launch of our proprietary brand, Solférino
·
The 10th
full paragraph relating to the 2 year extension of the Boucheron license for
existing fragrance lines
·
The 22nd
paragraph relating to forward-looking information
·
The
balance of such press release not otherwise incorporated by reference in Item
2.02.
Item 9.01
Financial Statements and Exhibits.
| 99.1 |
Our press release dated January 21, 2026
|
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.
Dated:
January 21, 2026
|
|
Interparfums, Inc.
|
|
|
|
|
|
By:
|
/s/ Michel Atwood
|
|
|
|
Michel Atwood,
|
|
|
|
Chief Financial Officer
|
